Search - tctmd.com

Displaying 41 - 60 of 1120

Sort: Relevancy | Date

News Industry News

Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events

November 02, 2016

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Todd Neale

November 02, 2016

Presentation TCT 2016

TAVR Complications: Have We Made Progress Over the Last Five Years?

Presenter: Ziyad M. Hijazi, David W.M. Muller, Cherradi rhizlan

November 01, 2016

Presentation TCT 2016

Ma Valve Ne Passes Pas La Valve!/My Valve Doesnt Cross the Valve!

Presenter: Bernard R. Chevalier, Philippe Généreux

November 01, 2016

Presentation TCT 2016

Tricuspid Valve-in-Valve and Valve-in-Ring Procedures and Outcomes

Presenter: Joachim Schofer, Alec S. Vahanian, Saif Anwaruddin

November 01, 2016

Presentation TCT 2016

TAVR Case Study With a Self-Expanding Valve

Presenter: Ziyad M. Hijazi, David W.M. Muller, Salem Abujalala

November 01, 2016

Presentation TCT 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer

November 01, 2016

Presentation TCT 2016

Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates From Deflect III and Reflect Clinical Trials

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Andreas Baumbach

November 01, 2016

Presentation TCT 2016

Transcatheter Tricuspid Valve Therapies 8: IVC/SVC Valved Stents - Results and a Case

Presenter: Joachim Schofer, Alec S. Vahanian, Alexander Lauten

November 01, 2016

Presentation TCT 2016

Pousser La Limite Du TAVI Transfemoral En Toute Prudence/How to Push the TF-TAVR Limit Safely!

Presenter: Bernard R. Chevalier, Philippe Généreux, Eric Van Belle

November 01, 2016

Presentation TCT 2016

TAVR Case Study: Rheumatic AS - Is TAVR Appropriate?

Presenter: Ziyad M. Hijazi, David W.M. Muller, Imad A. Alhaddad

November 01, 2016

Presentation TCT 2016

The REDUCE Trial: Will It Be Positive and What Will We Learn?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John F. Rhodes

November 01, 2016

Presentation TCT 2016

Cerebral Embolic Protection I: The Sentinel Filter - Design Features and Updates from CLEAN-TAVI, SENTINEL RCT, and Others

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Axel Linke

November 01, 2016

Presentation TCT 2016

Transcatheter Tricuspid Valve Therapies 7: TRAIPTA Description, Results and a Case

Presenter: Joachim Schofer, Alec S. Vahanian, Toby Rogers

November 01, 2016

Presentation TCT 2016

TAVR Case Study With a Balloon Expandable Valve

Presenter: Ziyad M. Hijazi, David W.M. Muller, Said Benghezel

November 01, 2016

Presentation TCT 2016

What Should Be the Next Series of Clinical Trials in PFO Closure?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John D. Carroll

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality of Life

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Ganesh Manoharan

November 01, 2016

Presentation TCT 2016

Transcatheter Tricuspid Valve Therapies 6: Cardioband TR Description, Results and a Case

Presenter: Joachim Schofer, Alec S. Vahanian, Karl-Heinz Kuck

November 01, 2016

Presentation TCT 2016

Management of Residual Leaks After LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw

November 01, 2016

Advertisement

Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

TAVR Complications: Have We Made Progress Over the Last Five Years?

Ma Valve Ne Passes Pas La Valve!/My Valve Doesnt Cross the Valve!

Tricuspid Valve-in-Valve and Valve-in-Ring Procedures and Outcomes

TAVR Case Study With a Self-Expanding Valve

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates From Deflect III and Reflect Clinical Trials

Transcatheter Tricuspid Valve Therapies 8: IVC/SVC Valved Stents - Results and a Case

Pousser La Limite Du TAVI Transfemoral En Toute Prudence/How to Push the TF-TAVR Limit Safely!

TAVR Case Study: Rheumatic AS - Is TAVR Appropriate?

The REDUCE Trial: Will It Be Positive and What Will We Learn?

Cerebral Embolic Protection I: The Sentinel Filter - Design Features and Updates from CLEAN-TAVI, SENTINEL RCT, and Others

Transcatheter Tricuspid Valve Therapies 7: TRAIPTA Description, Results and a Case

TAVR Case Study With a Balloon Expandable Valve

What Should Be the Next Series of Clinical Trials in PFO Closure?

Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality of Life

Transcatheter Tricuspid Valve Therapies 6: Cardioband TR Description, Results and a Case

Management of Residual Leaks After LAA Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content